Fundraising Fox
/Companies
Sign in

BeBetter Medicine

1 known investors

Find your way into BeBetter Medicine

Sign up to see every warm intro you have to BeBetter Medicine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BeBetter Medicine team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Guangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.

Investors · 1

Frequently asked questions

What does BeBetter Medicine do?
Guangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.
Who are BeBetter Medicine's investors?
BeBetter Medicine's investors include Ming capital.